The ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP) is pleased to announce that the Changchun Institute of Applied Chemistry (CIAC) is now a Partner Organisation of the CNBP with Dr Xiaohui Wang (pictured) leading the relationship from the CIAC side as a formal CNBP Partner Investigator.
Collaboration activity to take place between CNBP and CIAC will be focused in the areas of innate immune targeted biosensors and novel pharmacology. More specifically, CIAC expertise will feed into CNBP’s advanced research program exploring the impact of innate immune signalling in pain processing.
In a similar manner, CNBP will bring to CIAC and Dr Xiaohui Wang’s team a unique set of pre-clinical behavioural models and application areas that will advance the CIAC research program more broadly across the synthetic chemistry space.
Prof Mark Hutchinson, CNBP Director, noted that Dr Xiaohui Wang already possessed strong linkages with CNBP following Dr Wang’s visits to several CNBP nodes, and the decadal collaboration between the two researchers stemming from their time working together at the Center for Neuroscience at the University of Colorado, Boulder USA.
“I look forward to our future co-operative activity,” says Prof Mark Hutchinson. “CNBP and CIAC are an excellent strategic partnership fit in the novel innate immune targeted chemistry and pain-signalling space and I’m extremely excited to see where our joint research activity takes us.”
As a part of the partnership, CIAC will fund a full-time PhD student working on CNBP-CIAC related projects as well as provide additional research funding to support project activity and materials.
Below – Dr Xiaohui Wang.